| Cash Flow | 2025-06-30 |
|---|---|
| Stock-based compensation | 136 |
| Net loss | -7,449 |
| Amortization of right of use assets | 59 |
| Prepaid drug product | -600 |
| Other current assets | -1,283 |
| Lease liabilities | -58 |
| Interest payable | 51 |
| Accounts payable and accrued expenses | 4,122 |
| Change in fair value of warrant liability | -394 |
| Depreciation | 14 |
| Amortization of debt issuance costs | 40 |
| Net cash used in operating activities | -1,596 |
| Net proceeds from exercise of pre-funded warrants | 1 |
| Proceeds from promissory notes | 422 |
| Net cash provided by financing activities | 423 |
| Net increase (decrease) in cash | -1,173 |
BIO-PATH HOLDINGS, INC. (BPTH)
BIO-PATH HOLDINGS, INC. (BPTH)